Medtronic to acquire interbody implants maker Titan Spine

Medtronic has signed a definitive agreement to acquire Titan Spine, a privately held titanium spine interbody implant and surface technology company. The boards of directors of both companies have unanimously approved the transaction.

Titan Spine manufactures interbody implants, which are used as spacers, inserted between the vertebrae during spinal fusion surgery to help relieve pressure on nerves and hold the vertebrae in place while fusion occurs. During fusions, the material and shape of implants play key role in the bone growth process, because of which there is a growing demand from surgeons for titanium interbody devices.

Medtronic is expected to strengthen its position in procedural solutions for spine surgery, through the acquisition of Titan Spine. The acquisition includes Titan Spine’s complete portfolio, which consists of a comprehensive line of titanium, surface-enhanced interbody fusion devices.

The transaction is subject to the satisfaction of customary closing conditions including receipt of regulatory clearances and is expected to be closed within the Medtronic’s first fiscal quarter ending 26 July 2019.

Headquartered in Mequon, Wisconsin, Titan Spine markets a full line of endoskeleton interbody devices featuring its proprietary textured surface in the U.S., Europe, and Australia.